Get the Stockscreener App
21.80
0.27%
-0.0581
After Hours:
22.18
0.375
+1.72%
Vtv Therapeutics Inc stock is traded at $21.80, with a volume of 1,713.
It is down -0.27% in the last 24 hours and up +10.35% over the past month.
vTv Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin, being investigated for the treatment of type 1 diabetes (T1D). Its product pipeline includes TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
See More
Previous Close:
$21.86
Open:
$22.5
24h Volume:
1,713
Relative Volume:
0.31
Market Cap:
$57.07M
Revenue:
$17,000
Net Income/Loss:
$-23.87M
P/E Ratio:
-6.9888
EPS:
-3.12
Net Cash Flow:
$-22.03M
1W Performance:
-3.47%
1M Performance:
+10.35%
6M Performance:
+16.17%
1Y Performance:
+59.28%
1-Day Range:
$20.25
$22.50
1-Week Range:
$20.25
$23.05
52-Week Range:
$12.62
$26.99
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Name
Vtv Therapeutics Inc
Sector
Industry
Phone
336-841-0300
Address
3980 PREMIER DR, HIGH POINT, NC
Compare VTVT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
21.80 | 57.22M | 17,000 | -23.87M | -22.03M | -3.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-30-19 | Initiated | H.C. Wainwright | Buy |
| Apr-10-18 | Downgrade | Stifel | Buy → Hold |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-08-18 | Initiated | Northland Capital | Outperform |
| Sep-26-16 | Initiated | H.C. Wainwright | Buy |
| Sep-04-15 | Initiated | Canaccord Genuity | Buy |
| Aug-24-15 | Initiated | Piper Jaffray | Overweight |
| Aug-24-15 | Initiated | Stifel | Buy |
View All
Vtv Therapeutics Inc Stock (VTVT) Latest News
How vTv Therapeutics Inc. stock performs in rising dollar environment - newser.com
Can a trend reversal in vTv Therapeutics Inc. lead to recoveryPortfolio Gains Report & Consistent Income Trade Ideas - newser.com
Can vTv Therapeutics Inc. stock withstand economic slowdown2025 Winners & Losers & Daily Profit Focused Screening - newser.com
How cyclical is vTv Therapeutics Inc. (5VT0) stock compared to rivalsDip Buying & Long-Term Safe Investment Ideas - newser.com
Applying chart zones and confluence areas to vTv Therapeutics Inc.Inflation Watch & Free Risk Controlled Daily Trade Plans - newser.com
Strategies to average down on vTv Therapeutics Inc.Trade Risk Summary & Expert Curated Trade Setup Alerts - newser.com
Is vTv Therapeutics Inc. stock dividend yield sustainableWeekly Trend Recap & AI Driven Price Predictions - newser.com
Will vTv Therapeutics Inc. benefit from macro trendsQuarterly Profit Summary & High Win Rate Trade Tips - newser.com
Is vTv Therapeutics Inc. stock bottoming outWeekly Trade Report & Weekly Breakout Stock Alerts - newser.com
Tools to assess vTv Therapeutics Inc.’s risk profileProfit Target & Consistent Return Investment Signals - newser.com
Published on: 2025-10-10 04:14:14 - newser.com
vTv Therapeutics appoints four new members to scientific advisory board By Investing.com - Investing.com Nigeria
vTv Therapeutics (VTVT) Expands Scientific Advisory Board with N - GuruFocus
vTv Therapeutics appoints four new members to scientific advisory board - Investing.com
vTv Therapeutics Appoints Renowned Experts to Scientific Advisory Board for Cadisegliatin Development - Quiver Quantitative
vTv Therapeutics Announces New Appointments to its Scientific Advisory Board - GlobeNewswire
Visual analytics tools that track vTv Therapeutics Inc. performanceJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Price action breakdown for vTv Therapeutics Inc.Trade Signal Summary & High Accuracy Trade Alerts - newser.com
Reviewing Repligen (NASDAQ:RGEN) and vTv Therapeutics (NASDAQ:VTVT) - Defense World
What drives vTv Therapeutics Inc stock pricePrice Action Trading & Outperform the Market with Aggressive Picks - earlytimes.in
Order flow analysis tools used on vTv Therapeutics Inc.July 2025 Final Week & Free Expert Approved Momentum Trade Ideas - newser.com
Published on: 2025-10-06 05:06:17 - newser.com
Will vTv Therapeutics Inc. (5VT0) stock deliver compounding returns2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com
Can vTv Therapeutics Inc. (5VT0) stock withstand sector downturnsPortfolio Growth Summary & Growth-Oriented Investment Plans - newser.com
vTv Therapeutics Inc 5VT0 Stock Analysis and ForecastInterest Rate Changes & Affordable Trading Techniques - earlytimes.in
Published on: 2025-10-01 09:02:18 - newser.com
H.C. Wainwright Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $36 - 富途牛牛
What analysts say about vTv Therapeutics Inc stockCup and Handle Formations & High Yield Stock Picks - earlytimes.in
Is it time to cut losses on vTv Therapeutics Inc.July 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
Multi asset correlation models including vTv Therapeutics Inc.2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com
Is vTv Therapeutics Inc 5VT0 a good long term investmentVolatility Index Analysis & You’ll Thank Yourself in 6 Months - Early Times
vTv Therapeutics (NASDAQ:VTVT) Share Price Passes Above 50 Day Moving AverageTime to Sell? - MarketBeat
Will vTv Therapeutics Inc. rebound enough to break evenJuly 2025 PreEarnings & Weekly High Momentum Picks - newser.com
vTv Therapeutics Inc. recovery potential after sell offQuarterly Performance Summary & Low Risk High Win Rate Picks - newser.com
Multi factor analysis applied to vTv Therapeutics Inc.2025 Valuation Update & Weekly Breakout Watchlists - newser.com
Can swing trading help recover from vTv Therapeutics Inc. lossesLong Setup & Expert Approved Momentum Trade Ideas - newser.com
Published on: 2025-09-21 06:18:52 - newser.com
Vtv Therapeutics Inc Stock (VTVT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):